The epithelial–mesenchymal transition (EMT) is a cellular reprogramming process that
occurs during embryonic development and adult tissue homeostasis. This process involves …

Minimal Residual Disease (MRD) detection has emerged as an independent factor in
clinical and pathological cancer assessment offering a highly effective method for predicting …

DNA methylation is a fundamental mechanism of epigenetic control in cells and its
dysregulation is strongly implicated in cancer development. Cancers possess an extensively …

Gastrointestinal (GI) cancers account for one-fourth of the global cancer incidence and are
incriminated to cause one-third of cancer-related deaths. GI cancer includes esophageal …

There is considerable interest in and enthusiasm for quantitative tests for residual cancer
cells in the context of cancer therapy, a concept referred to as measurable residual disease …

Abstract Background Circulating tumor DNA (ctDNA) has emerged as a potential diagnostic
and prognostic biomarker in various tumors. However, the role of tumor suppressor genes …

Minimal residual disease (MRD) is termed as the small numbers of remnant tumor cells in a
subset of patients with tumors. Liquid biopsy is increasingly used for the detection of MRD …

Background Recurrent metastasis after radical resection in patients of colorectal cancer
(CRC) is a great challenge for the world, in which genomic alterations play a major role in …

Summary Background Circulating tumour DNA (ctDNA)-based molecular residual disease
(MRD) detection technology has been widely used for recurrence evaluation, but there is no …

Background The molecular complexity of colorectal cancer poses a significant challenge to
the clinical implementation of accurate risk stratification. There is still an urgent need to find …